Investigational Drug Details
| Drug ID: | D403 |
| Drug Name: | Avandia |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 155141-29-0 |
| Repositioning for NAFLD: | No |
| SMILES: | O=C(O)C=CC(=O)O.O=C1SC(C(=O)N1)CC2=CC=C(OCCN(C3=NC=CC=C3)C)C=C2 |
| Structure: |
|
| InChiKey: | SUFUKZSWUHZXAV-BTJKTKAUSA-N |
| Molecular Weight: | 473.5 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT00699036) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0125 | NCT00699036 | Phase 2 | Unknown status | No Results Available | April 2007 | June 19, 2009 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|